维普中文期刊产品整合服务
18篇 您的检索式:作者名="Guss C"
    题名 作者 年代 出处 被引量
1Ala394Thr polymorphism in the clock gene NPAS2:a circadian modifier for the risk of nonHodgkin's lymphoma显示文摘Zhu Y Leaderer D Guss C 2007Int J Cancer2007,120,2:1
2Crystal structure of the topoisomerase II poison 9 - amino - acridine -4 -carboxamide bound to the DNA hexanucleotide d(CGTACG) 2 显示文摘Adams A Guss J M Collyer C A 1999Biochemistry1999,38,:1
3Experimental investigation of a 140 GHz gyrotron-back- ward wave oscillator 显示文摘BASTEN M A GUSS W C KREISCHER K E 1995International Journal of Infra- red Millimeter Waves1995,16,5:1
4Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma显示文摘Zhu Y Leaderer D Guss C 2007Int J Cancer2007,120,2:1
5An antiserum against protamines for immunohistochemical studies of histone to protamine transition during human spermiogenesis显示文摘C Roux M Gusse P Chevaillier JP Dadoune 1988J Reprod Fertil1988,2,1:1
6The Kenna urcilite: An uhramafic rock with evidence for igneous, metamorphic, and shock origin显示文摘Berkley J L Brown H G IV Keil K Carter N L Mercier J C Guss G 1976Geochim Cosmochim Acta1976,40,12:1
7Symptomatic venous throm-bo-embolism in low-energy isolated fractures in hospitalised patients显示文摘Prensky C Urruela A Guss MS 2013Injury2013,44,8:1
8White-rot fungi demonstrate first biodegradation of phenolic resin显示文摘A C Gusse P D Miller T J Volk 2006Environ Sci Technol2006,40,13:1
9Velocity ratio measurements of a gyrotron electron beam显示文摘Guss W C Grimm T L Kreiseher K E 1991J Appl Phys1991,69,7:1
10Blood pressure surge on rising显示文摘Gusse P Lasserre R Minific C 2004Hypertens2004,22,:1
11An antiserum against pintamines for studies of histone to protamine transition during human spermiogenesis 显示文摘Roux C Gusse M Chevaillier P 1988Journal of Reproduction and Fertility1988,,82:1
12Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non Hodgkin' s lymphoma显示文摘Zhu Y Leaderer D Guss C 2007Int J Cancer2007,120,:1
13Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non- Hodgkin~ lymphoma显示文摘Zhu Y Leaderer D Guss C 2007Int J Cancer2007,120,2:1
14The Disaster Continues: A Qualitative Study on the Experiences of Displaced Hurricane Katrina Survivors显示文摘Tuason M T G Guss C D Carroll L 2012Professional Psychology : Research and Practice2012,43,4:1
15Cross sections and analyzing powers for fast neutron scattering to the ground and first excited states of 58Ni and 60Ni显示文摘GUSS P P BYRD R C FLOYD C E 1985Nucl Phys1985,,438:1
16A faculty development program to train tutors to be discussion leaders rather than facilitators显示文摘Shields H M Guss D Somers S C 2007Acad Med2007,82,5:1
17Role of plantar plate and surgical reconstruction techniques on static stability of lesser metatar- sophalangealjoints: abiomechanicalstudy显示文摘Chalayon O Chertman C Guss AD 2013Foot Ankle Int2013,34,:1
18Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands:Analysis of 2210 patients显示文摘BACKGROUND Mucoepidermoid carcinoma(MEC)is a rare malignancy of the head and neck;however,it accounts for a majority of the tumors of the salivary glands.This study used a national population-based registry to describe the pre-treatment and treatment-related prognostic factors that influence survival in patients with MEC of the major salivary glands.To our knowledge,this is the largest populationbased study examining predictors of both overall and cause-specific survival of MEC of the major salivary glands.AIM To identify prognostic factors influencing overall survival(OS)and cause-specific survival(CSS)of patients with MEC of the major salivary glands.METHODS We used the Surveillance,Epidemiology and End-Results Database of the National Cancer Institute to investigate a variety of factors that could influence survival of patients diagnosed with mucoepidermoid carcinoma of the major salivary glands.A total of 2210 patients diagnosed with MEC of the major salivary glands during the years of 1975-2016 were studied.The primary endpoints were OS and CSS.Cox regression analysis was used to perform univariate and multivariate analyses of clinical variables such as age at diagnosis,diagnosis year,sex,race,tumor size,stage,grade,treatment with or without surgical excision,and adjuvant radiotherapy treatment.RESULTS A total of 2210 patients diagnosed with MEC of the major salivary glands met inclusion criteria.In this study,95%of patients underwent surgical excision and 41%received adjuvant radiation therapy.Median OS time for Grade I,II,and III/IV was 401 mo(±48.25,95%CI),340 mo(±33.68,95%CI)and 55 mo(±11.05,95%CI),respectively.Univariate analysis revealed that lack of surgical excision was associated with decreased OS[hazard ratio(HR)4.26,P<0.0001]and that patients with localized disease had improved OS compared to both regional and distant disease(HR 3.07 and 6.96,respectively,P<0.0001).Additionally,univariate analysis demonstrated that male sex,age over 50 at diagnosis,Grade III tumors,and increasing tumor size were associated with worsened OS(P<0.0006).Univariate analysis of CSS similarly revealed that lack of surgical excision and Grade III carcinoma conferred decreased CSS(HR 4.37 and 5.44,respectively,P<0.0001).Multivariate analysis confirmed that increasing age,in 10-year age bands,advanced tumor stage,increasing tumor size,Grade III carcinoma,male sex,and lack of surgical excision were associated with a statistically significant decrease in OS and CSS(P<0.04).Of note,multivariate analysis revealed that the use of adjuvant radiation therapy was not associated with improved OS or CSS.CONCLUSION Multivariate analysis demonstrated increasing age,advanced tumor stage,increasing tumor size,Grade III carcinoma,male sex,and lack of surgical excision were associated with decreased OS and CSS(P<0.04).Zachary C Taylor Erin A Kaya Jeffrey D Bunn Zachary D Guss Brian J Mitchell Robert K Fairbanks Wayne T Lamoreaux Aaron E Wagner Ben J Peressini Christopher M Lee 2020World Journal of Clinical Oncology2020,11,12:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费